Status:
COMPLETED
Evaluation of Efficacy and Safety of Epidural Steroid Injection Using Dexamethasone or Betamethasone
Lead Sponsor:
Seoul National University Bundang Hospital
Conditions:
Back Pain
Neck Pain
Eligibility:
All Genders
19+ years
Phase:
NA
Brief Summary
Particle steroid drug such as triamcinolone has been used widely for epidural steroid injection (ESI) treatment in Korea. However, Korea FDA recently prohibit ESI using triamcinolone, following the re...
Eligibility Criteria
Inclusion
- patients with spinal pain (i.e.neck pain, back pain, or radiculopathy..)
- patients with informed consent
- visual analog scale (VAS) is five or more in 10-point scale at screening
- sustained spinal pain, regardless of sufficient conservative treatment (i.e. oral medicine, physical therapy..)
Exclusion
- age of patient less than 19 years
- relative contraindication of epidural steroid injection, as follows:
- pregnant or breast-feeding state
- uncontrolled coagulopathy
- suspected of active infection state
- uncontrolled diabetes mellitus
- previous history of adverse event related to epidural steroid injection
Key Trial Info
Start Date :
October 1 2013
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2015
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT01885481
Start Date
October 1 2013
End Date
April 1 2015
Last Update
March 30 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Seoul National University Bundang Hospital
Seongnam-si, Gyeonggi-do, South Korea, 763-707